Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA: a cancer journal for clinicians, 2017. 67(1): p. 7–30.

Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ, 2020. 371.

Erickson BK, Conner MG, Landen CN Jr. The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 2013;209(5):409–14.

Article  PubMed  PubMed Central  Google Scholar 

Bankhead C, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG: An International Journal of Obstetrics & Gynaecology. 2008;115(8):1008–14.

Article  CAS  Google Scholar 

Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chin Clin Oncol. 2020;9(4):47.

Article  PubMed  Google Scholar 

van Nagell JR Jr, Ueland FR. Ultrasound evaluation of pelvic masses: predictors of malignancy for the general gynecologist. Curr Opin Obstet Gynecol. 1999;11(1):45–9.

Article  PubMed  Google Scholar 

Granberg S, Wikland M, Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol. 1989;35(2):139–44.

Article  CAS  PubMed  Google Scholar 

Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol. 2009;14(5):378.

Article  PubMed  Google Scholar 

Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351(24):2519–29.

Article  CAS  PubMed  Google Scholar 

Ito C et al. Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of Chondrocytes BioMed research international, 2017. 2017.

Zhao Z, et al. Tumor protein D52 (TPD52) inhibits growth and metastasis in renal cell carcinoma cells through the PI3K/Akt signaling pathway. Oncol Res. 2017;25(5):773.

Article  PubMed  PubMed Central  Google Scholar 

Messenger SW, et al. Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells. Am J Physiology-Gastrointestinal Liver Physiol. 2013;305(6):G439–52.

Article  CAS  Google Scholar 

Shehata M et al. Tumor protein D52 overexpression and gene amplification in cancers from a mosaic of microarrays. Crit Reviews™ Oncog, 2008. 14(1).

Largo C, et al. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. Haematologica. 2006;91(2):184–91.

CAS  PubMed  Google Scholar 

Tennstedt P, et al. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR. Int J Oncol. 2014;44(2):609–15.

Article  CAS  PubMed  Google Scholar 

Guo H, et al. The PI3K/AKT pathway and renal cell carcinoma. J Genet Genomics. 2015;42(7):343–53.

Article  PubMed  PubMed Central  Google Scholar 

Sourbier C, et al. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res. 2006;66(10):5130–42.

Article  CAS  PubMed  Google Scholar 

Dasari C, et al. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells. Tumor Biology. 2017;39(5):1010428317698382.

Article  PubMed  Google Scholar 

Wang Y, et al. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. 2016;7(5):6323.

Article  PubMed  Google Scholar 

Ding J, et al. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial–mesenchymal transition by targeting FBXW7. Acta Biochim Biophys Sin. 2018;50(6):597–604.

Article  CAS  PubMed  Google Scholar 

Tachibana H, et al. Circulating miR-223 in oral cancer: its potential as a novel diagnostic biomarker and therapeutic target. PLoS ONE. 2016;11(7):e0159693.

Article  PubMed  PubMed Central  Google Scholar 

Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–37.

Article  CAS  PubMed  Google Scholar 

Dong J, et al. miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. J bone Oncol. 2016;5(2):74–9.

Article  PubMed  PubMed Central  Google Scholar 

Nian W, et al. miR–223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin–like growth factor–1 receptor and cyclin-dependent kinase 2. Oncol Lett. 2013;6(2):359–66.

Article  PubMed  PubMed Central  Google Scholar 

Simmen FA, et al. The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reproductive Biology and Endocrinology. 2008;6(1):41.

Article  PubMed  PubMed Central  Google Scholar 

Denver RJ, et al. Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system: evidence for a role in neurite outgrowth. J Biol Chem. 1999;274(33):23128–34.

Article  CAS  PubMed  Google Scholar 

Tupler R, Perini G, Green MR. Expressing the human genome. Nature. 2001;409(6822):832–3.

Article  CAS  PubMed  Google Scholar 

Diakiw SM, et al. Methylation of KLF 5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival. Br J Haematol. 2013;161(6):884–8.

Article  CAS  PubMed  Google Scholar 

Ying M, et al. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells. 2011;29(1):20–31.

Article  CAS  PubMed  Google Scholar 

Ying M, et al. KLF9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells. 2011;29(1):20.

Article  CAS  PubMed  Google Scholar 

Ye S, et al. Wnt/β-catenin and LIF–Stat3 signaling pathways converge on Sp5 to promote mouse embryonic stem cell self-renewal. J Cell Sci. 2016;129(2):269–76.

CAS  PubMed  PubMed Central  Google Scholar 

Jeong J-W. In search of molecular mechanisms in endometriosis. Oxford University Press; 2014.

Tetreault M-P, Yang Y, Katz JP. Krüppel-like factors in cancer. Nat Rev Cancer. 2013;13(10):701–13.

Article  CAS  PubMed  Google Scholar 

Gorin MA, Pan Q. Protein kinase Cε: an oncogene and emerging tumor biomarker. Mol Cancer. 2009;8(1):9.

Article  PubMed  PubMed Central  Google Scholar 

Martínez-Gimeno C, et al. Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: εPKC, a novel prognostic factor for relapse and survival. Head Neck. 1995;17(6):516–25.

Article  PubMed  Google Scholar 

Wheeler DL, et al. Overexpression of protein kinase C-ε in the mouse epidermis leads to a spontaneous myeloproliferative-like disease. Am J Pathol. 2005;166(1):117–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharif TR, Sharif M. Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. Int J Oncol. 1999;15(2):237–80.

CAS  PubMed  Google Scholar 

Xiao H, Goldthwait DA, Mapstone T. The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J Neurosurg. 1994;81(5):734–40.

Article  CAS  PubMed  Google Scholar 

Pan Q, et al. Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res. 2006;66(19):9379–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauvin L, et al. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating akt and PKCε/δ-induced ERK pathways. Biochim et Biophys Acta (BBA)-Molecular Cell Biology Lipids. 2016;1861(4):380–90.

CAS  Google Scholar 

Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

Article  Google Scholar 

Zahra K, et al. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression. Sci Rep. 2022;12(1):1–18.

Article  Google Scholar 

Khan K et al. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer BioMed research international, 2020. 2020.

Shabbir M, et al. Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers. Sci Rep. 2021;11(1):1–21.

Article  Google Scholar 

Yang J, et al. The I-TASSER suite: protein structure and function prediction. Nat Methods. 2015;12(1):7–8.